Threshold Pharmaceuticals, Inc. (NASDAQ:THLD)
CAPS Rating:
A biotechnology company focused on the discovery and development of small molecule therapeutics for the potential treatment of cancer.
A biotechnology company focused on the discovery and development of small molecule therapeutics for the potential treatment of cancer.
Recs
http://caps.fool.com/Blogs/fund-trades/779590.
http://twitter.com/portefeuillefun.